Cargando…

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management

BACKGROUND: Annually, 10% of warfarin patients will likely need to stop warfarin prior to elective surgery to achieve a baseline international normalization ratio (INR) level (INR ≤ 1.2) at the time of the procedure. This study explores the influence of genetic and non-genetic factors on INR normali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eljilany, Islam, Elarref, Mohamed, Shallik, Nabil, Elzouki, Abdel-Naser, Bader, Loulia, El-Bardissy, Ahmed, Abdelsamad, Osama, Al-Badriyeh, Daoud, Cavallari, Larisa H, Elewa, Hazem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409603/ https://www.ncbi.nlm.nih.gov/pubmed/34483679 http://dx.doi.org/10.2147/PGPM.S322743

Ejemplares similares

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey
por: Eljilany, Islam, et al.
Publicado: (2020)

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
por: Salem, Muhammad, et al.
Publicado: (2021)

The Impact of Genetic and Non-Genetic Factors on Warfarin Dose Prediction in MENA Region: A Systematic Review
por: Bader, Loulia Akram, et al.
Publicado: (2016)

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
por: Eljilany, Islam, et al.
Publicado: (2021)

Effect of SAMe-TT(2)R(2) score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
por: Elewa, Hazem, et al.
Publicado: (2020)

Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report
por: Fahmi, Amr Mohamed, et al.
Publicado: (2016)

Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
por: El Rouby, Nihal, et al.
Publicado: (2021)

Evaluation of the Validity of SAMe-TT(2)R(2) Score in a Cohort of Venous Thromboembolism Patients Treated With Warfarin
por: Alhmoud, Eman Nawash, et al.
Publicado: (2020)

Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
por: Al Mukdad, Mohammad, et al.
Publicado: (2019)

D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review
por: Eljilany, Islam, et al.
Publicado: (2020)

Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021)

A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR
por: Ur Rahman, Saad
Publicado: (2023)

Predictors for INR-control in a well-managed warfarin treatment setting
por: Björck, Fredrik, et al.
Publicado: (2018)

Genetic Factors Associated with Morphine Consumption in Women Undergoing Laparoscopic Cholecystectomy: A Prospective Cohort Study
por: Elgendy, Hamed M, et al.
Publicado: (2023)

Optimal INR level for warfarin therapy after mechanical mitral valve replacement
por: Kamthornthanakarn, Itthidet, et al.
Publicado: (2019)

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users
por: Dumas, Stephanie, et al.
Publicado: (2016)

Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar
por: Alhmoud, Eman, et al.
Publicado: (2020)

Enoxaparin-sodium/heparin/warfarin: Heparin-induced thrombocytopenia and elevated INR: case report
Publicado: (2021)

Determining INR Awareness of the Patients who Use Warfarin and Rates of Achieving the Target Dosage
por: Demir, Nazan, et al.
Publicado: (2020)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

UNUSUAL WARFARIN DOSE TO ACHIEVE THERAPEUTIC INR IN A 4-MONTH OLD CHILD: NON-GENETICS RISK FACTORS ARE STILL A CHALLENGE
por: Okumura, Lucas Miyake, et al.
Publicado: (2017)

Does prophylactic antibiotic administration for tooth extraction affect PT-INR in patients taking warfarin?
por: Iwata, Eiji, et al.
Publicado: (2020)

Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures
por: Kampouraki, Emmanouela, et al.
Publicado: (2019)

Drive‐up INR testing and phone‐based consultations service during COVID‐19 pandemic in a pharmacist‐lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient‐ oriented outcomes
por: Alhmoud, Eman N., et al.
Publicado: (2021)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

Dynamic ‘Spot Sign’ Resolution following INR Correction in a Patient with Warfarin-Associated Intracerebral Hemorrhage
por: Chakraborty, S., et al.
Publicado: (2011)

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2014)

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
por: Watanabe, Norio, et al.
Publicado: (2017)

Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
por: Akamatsu, Hayato, et al.
Publicado: (2023)

Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review
por: Fahmi, Amr Mohamed, et al.
Publicado: (2022)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
por: Haug, Kari Bente Foss, et al.
Publicado: (2008)

How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?
por: Kim, Jun Hyung, et al.
Publicado: (2009)

Effects of structured patient education on knowledge level and INR control of patients receiving warfarin: Randomized Controlled Trial
por: Baysal, Ebru, et al.
Publicado: (2018)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
por: Luengsupabul, Sirote, et al.
Publicado: (2020)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Is intravenous thrombolysis safe for acute ischemic stroke patients taking warfarin with INR 1.9?: A case report
por: Li, Zhaokun, et al.
Publicado: (2020)

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation
por: İslam, Mehmet Muzaffer, et al.
Publicado: (2023)

Multi‐site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos
por: El Rouby, Nihal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t2jl1jvg7htuodsr4v8v1bl3ab